Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» CC-220
CC-220
5 Drugs That Could Make Celgene the Best Biotech Stock of the Next Decade
Motley Fool
Wed, 09/27/17 - 11:22 am
Celgene
ozanimod
GED-0301
luspatercept
marizomib
CC-220
Celgene’s oral lupus candidate shows ‘trend to improvement’ in small test
Fierce Biotech
Thu, 06/15/17 - 09:42 am
Celgene
lupus
CC-220
clinical trials
7 Reasons Celgene Is the Best Bet in Biotech
Motley Fool
Tue, 10/18/16 - 09:25 am
Celgene
ozanimod
CAR-T
CC-122
CC-220
demcizumab
Mongersen
AVL292